| Benefits of reduced mortality were seen in over-75s as well as younger patients Related items from OnMedica Overview of risk assessment and statin therapy Reducing threshold for statins even further might be cost-effective Major review clears statins New alternative to statins gets regulatory green light Never too old to benefit from CVD prevention |
Thursday, 10 November 2016
Higher dose statins could prolong lives of CVD patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment